Approval · Notice of Compliance 30524 · 2023
PRO-FLUCONAZOLE: Notice of Compliance 30524
Issued April 14, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30524
- Date
- April 14, 2023
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Labelling update to match licensor
- Canadian reference product
- DIFLUCAN (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PRO-FLUCONAZOLE | Not yet assigned | — |
Medicinal ingredients
- FLUCONAZOLE 100 MG per TAB